Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 155
2.
Sci Rep ; 14(1): 9803, 2024 04 29.
Article En | MEDLINE | ID: mdl-38684810

Mycoplasma pneumoniae necrotizing pneumonia (MPNP) has a long and severe disease course, which seriously threatens to jeopardize patients' lives and health. Early prediction is essential for good recovery and prognosis. In the present study, we retrospect 128 children with MPNP and 118 children with Mycoplasma pneumoniae pneumonia combined with pulmonary consolidation to explore the predictive value of lactate dehydrogenase (LDH) in children with MPNP by propensity score matching method, multiple logistic regression analysis, dose-response analysis and decision curve analysis. The WBC count, PLT count and percentage of neutrophils were significantly higher in necrosis group than consolidation group. The serum CRP, PCT, ESR, D-D, FIB, ALT, LDH, IgG and IgM were significantly higher in necrosis group. Compared to consolidation group, necrosis group is more severe in chest pain and dyspnea. Multivariate logistic regression analysis showed that duration of LDH levels, high fever, D-dimer, and fibrinogen were independent predictive factors for the incidence of MPNP. Restricted cubic spline analysis showed that a non-linear dose-response relationship between the continuous changes of LDH level and the incidence of MPNP. Decision curve analysis revealed that LDH had an important clinical value in predicting MPNP. This study provides a potential serologic indicator for early diagnosis of MPNP.


L-Lactate Dehydrogenase , Mycoplasma pneumoniae , Pneumonia, Mycoplasma , Pneumonia, Necrotizing , Humans , L-Lactate Dehydrogenase/blood , Male , Female , Pneumonia, Mycoplasma/diagnosis , Pneumonia, Mycoplasma/blood , Child , Child, Preschool , Pneumonia, Necrotizing/diagnosis , Retrospective Studies , Prognosis , Infant , Predictive Value of Tests , Biomarkers/blood , Decision Support Techniques
3.
Arch Pediatr ; 31(3): 183-187, 2024 Apr.
Article En | MEDLINE | ID: mdl-38485569

BACKGROUND: Necrotizing pneumonia (NP) is a serious and rare disease in children. Pediatric data on NP are limited and the impact of the 13-valent pneumococcal conjugate vaccine has been very poorly evaluated. PATIENTS AND METHODS: We conducted a retrospective study at Toulouse University Hospital between 2008 and 2018. Children who presented with thin-walled cavities in the areas of parenchymal consolidation on imaging were included in the study. RESULTS: The incidence of NP did not decrease during this period. Bacterial identification occurred in 56% of cases (14/25) and included six cases of Streptococcus pneumoniae, five of Staphylococcus aureus, two of Streptococcus pyogenes, and one of Streptococcus viridans. Streptococcus pneumoniae NP are more frequently associated with empyema/parapneumonic effusion compared to S. aureus NP (p = 0.02). Patients with S. pyogenes NP more often required volume expansion than did S. pneumoniae cases (p = 0.03). When comparing children born before and after implementation of the 13-valent pneumococcal conjugate vaccine, we identified a relative modification of the bacterial epidemiology, with an increase in the proportion of S. pyogenes NP and S. aureus NP and a decrease in the proportion of NP caused by S. pneumoniae. CONCLUSION: Future studies are needed to assess the epidemiology of NP in children. Continued surveillance of identified pneumococcal serotypes is essential to document epidemiological changes in the coming years.


Pneumococcal Infections , Pneumonia, Necrotizing , Pneumonia, Pneumococcal , Child , Humans , Infant , Pneumococcal Infections/epidemiology , Pneumococcal Vaccines , Pneumonia, Necrotizing/diagnostic imaging , Pneumonia, Necrotizing/epidemiology , Pneumonia, Pneumococcal/diagnostic imaging , Pneumonia, Pneumococcal/epidemiology , Retrospective Studies , Staphylococcus aureus , Streptococcus pneumoniae , Streptococcus pyogenes , Tertiary Care Centers , Vaccines, Conjugate
10.
Cas Lek Cesk ; 162(4): 160-163, 2023.
Article En | MEDLINE | ID: mdl-37734942

Although pneumonia presents a relatively common diagnosis, it does not always present with classic clinical symptoms, nor does it follow a regular course without complications. The presented case describes a rare case of aspiration necrotizing pneumonia, which despite intensive therapy, progressed to lung gangrene and required a lung lobectomy. Another peculiarity is that the correct diagnosis was established only after the onset of abdominal pain, surprisingly by a trauma surgeon. This case emphasizes the necessity of a thorough general examination and draws attention to a rare, but conservatively intractable necrotizing pneumonia complicated by lung gangrene.


Pneumonia, Aspiration , Pneumonia, Necrotizing , Humans , Child, Preschool , Gangrene , Abdominal Pain , Lung
11.
Rev Iberoam Micol ; 40(2-3): 26-30, 2023.
Article En | MEDLINE | ID: mdl-37714729

BACKGROUND: Immune checkpoint inhibitors (ICIs) are a promising new treatment for different types of cancer. The infectious complications in patients taking ICIs are rare. CASE REPORT: A 58-year-old male who received chemotherapy consisting of pembrolizumab (PD-1 inhibitor) for esophagus squamous cell carcinoma one month before was admitted to the emergency room with shortness of breath soon after fiberoptic bronchoscopy, which was done for the inspection of the lower airway. A computed tomography of the chest revealed a progressive consolidation on the right upper lobe. Salmonella group D was isolated from the bronchoalveolar lavage (BAL) fluid culture. The fungal culture of the same clinical sample yielded Aspergillus niger; furthermore, a high titer (above the cut-off values) of Aspergillus antigen was found both in the BAL fluid and serum of the patient. Despite the effective spectrum and appropriate dose of antimicrobial treatment, the patient died due to disseminated intravascular coagulopathy. CONCLUSIONS: Awareness of unusual pathogens in the etiology of pneumonia after ICI treatment may help to avoid underdiagnosis.


Immune Checkpoint Inhibitors , Pneumonia, Necrotizing , Male , Humans , Middle Aged , Pneumonia, Necrotizing/pathology , Aspergillus , Lung/microbiology , Bronchoalveolar Lavage Fluid/microbiology , Salmonella
14.
Inn Med (Heidelb) ; 64(11): 1119-1122, 2023 Nov.
Article De | MEDLINE | ID: mdl-37296328

A 29-year-old Indian patient was admitted to the authors' pulmonary clinic with cough and fever. Community-acquired pneumonia was initially suspected. Various antibiotic therapies were administered, which did not lead to any clinical improvement. Despite detailed diagnostics, no pathogen was found. Computed tomography showed rapidly progressive pneumonia in the left upper lobe. Since the infection could not be managed conservatively, upper lobe resection was performed. Histologically, an amoebic abscess was found to be the cause of the infection. Since cerebral and hepatic abscesses were also found, hematogenous dissemination may be assumed.


Amebiasis , Lung Abscess , Pneumonia, Necrotizing , Pneumonia , Humans , Adult , Pneumonia, Necrotizing/diagnosis , Lung/pathology , Amebiasis/pathology , Pneumonia/diagnosis , Lung Abscess/diagnosis
15.
BMJ Case Rep ; 16(6)2023 Jun 20.
Article En | MEDLINE | ID: mdl-37339824

Mycoplasma hominis, a common coloniser of the urogenital tract, is a rare cause of respiratory infections in an immunocompetent patient. M. hominis lacks a cell wall and can be difficult to identify with standard culture methods posing difficulties in diagnosis and treatment. We describe a case of M. hominis pneumonia in an immunocompetent man in his early 40s without any risk factors presenting with a cavitary lesion who developed empyema and necrotising pneumonia requiring surgical debridement. Identification of M. hominis and subsequent modification of antibiotic therapy led to favourable outcome. M. hominis should be considered in the differential diagnosis of patients with treatment resistant pneumonia especially in patients with trauma, intracranial injury, lung transplant or if immunocompromised. While M. Hominis is naturally resistant to all antibiotics that target cell wall synthesis, we recommend levofloxacin or other fluoroquinolone to most effectively treat with doxycycline as a potential alternative.


Mycoplasma Infections , Pneumonia, Necrotizing , Pneumonia , Humans , Male , Adult , Mycoplasma hominis , Mycoplasma Infections/complications , Mycoplasma Infections/diagnosis , Mycoplasma Infections/drug therapy , Pneumonia, Necrotizing/drug therapy , Anti-Bacterial Agents/therapeutic use , Pneumonia/drug therapy
16.
Rev. iberoam. micol ; 40(2/3): 26-30, Abr-Jun, 2023. tab, ilus
Article En | IBECS | ID: ibc-228371

Background: Immune checkpoint inhibitors (ICIs) are a promising new treatment for different types of cancer. The infectious complications in patients taking ICIs are rare. Case report: A 58-year-old male who received chemotherapy consisting of pembrolizumab (PD-1 inhibitor) for esophagus squamous cell carcinoma one month before was admitted to the emergency room with shortness of breath soon after fiberoptic bronchoscopy, which was done for the inspection of the lower airway. A computed tomography of the chest revealed a progressive consolidation on the right upper lobe. Salmonella group D was isolated from the bronchoalveolar lavage (BAL) fluid culture. The fungal culture of the same clinical sample yielded Aspergillus niger; furthermore, a high titer (above the cut-off values) of Aspergillus antigen was found both in the BAL fluid and serum of the patient. Despite the effective spectrum and appropriate dose of antimicrobial treatment, the patient died due to disseminated intravascular coagulopathy. Conclusions: Awareness of unusual pathogens in the etiology of pneumonia after ICI treatment may help to avoid underdiagnosis.(AU)


Antecedentes: Los fármacos inhibidores de puntos de control inmunitario (ICI) son una nueva y prometedora opción de tratamiento para diferentes tipos de cáncer. Las complicaciones infecciosas en pacientes que toman ICI son poco frecuentes. Caso clínico: Un varón de 58 años que recibió quimioterapia con pembrolizumab (inhibidor de PD-1) para un carcinoma de células escamosas de esófago hacía un año, ingresó en Urgencias por dificultad respiratoria poco después de realizarse una broncoscopia de fibra óptica para una inspección de las vías aéreas inferiores. La tomografía computarizada de tórax reveló una consolidación progresiva en el lóbulo superior derecho. Se aisló Salmonella grupo D en el cultivo del líquido de lavado broncoalveolar (LBA). En el cultivo de hongos de la misma muestra creció Aspergillus niger; además, se detectó antígeno (por encima de los valores de corte) de Aspergillus tanto en la muestra del LBA como en el suero del paciente. A pesar del espectro eficaz y la dosis adecuada del antifúngico utilizado, el paciente falleció debido a una coagulopatía intravascular diseminada. Conclusiones: El conocimiento de patógenos inusuales en la etiología de la neumonía tras el tratamiento con ICI puede ayudar a evitar el infradiagnóstico.(AU)


Humans , Male , Middle Aged , Pneumonia, Necrotizing/drug therapy , Esophageal Neoplasms/drug therapy , /drug therapy , Typhoid Fever , Invasive Pulmonary Aspergillosis , Inpatients , Physical Examination , Mycology , Pneumonia, Necrotizing/diagnosis , Pneumonia, Necrotizing/microbiology , Salmonella
17.
Ann Clin Microbiol Antimicrob ; 22(1): 36, 2023 May 13.
Article En | MEDLINE | ID: mdl-37179313

INTRODUCTION: Curvularia hawaiiensis (formerly Bipolaris hawaiiensis) is a plant pathogen often isolated from soil and vegetative material. However, only a few cases of opportunistic invasive infections in humans have been described. CASE: A 16-year-old female patient without comorbidities was admitted to the emergency department because of fever and chest pain. We described the first coinfection of Curvularia hawaiiensis and Mycobacterium tuberculosis necrotising pneumonia. DISCUSSION: Multiple infections can alter immune responses. However, immunosuppression is the most critical risk factor for infection with species of the genus Curvularia. Therefore, it is crucial to carefully examine patients with tuberculosis, as they may rarely be coinfected with unusual fungi.


Ascariasis , Coinfection , Mycobacterium tuberculosis , Pneumonia, Necrotizing , Humans , Adolescent , Curvularia , Coinfection/diagnosis
18.
BMC Pediatr ; 23(1): 170, 2023 04 13.
Article En | MEDLINE | ID: mdl-37046243

BACKGROUND: Necrotizing pneumonia is rare in children and is one of the most serious complications of a lung infection caused by antibiotic failure. We present a 12-year-old leukopenic child with a long-lasting lung infection, presenting as having a lung hydatid cyst, but diagnosing with necrotizing pneumonia in the right bilobed lung. Failure to medical treatment and ongoing leukopenia justified surgical intervention with positive results. CASE PRESENTATION: The patient was referred to our teaching hospital's pediatric surgery department. He had previously been diagnosed with intestinal tuberculosis (TB) and received anti-TB treatment. On referral to our hospital, the patient was suffering from restlessness, frequent coughing, fever, vomiting, and diarrhea. Following the completion of the clinical work-up, a blood test revealed leukopenia (white blood cell count of 2100/microliter), a normal platelet count, and a lesion in the right lung. Computerized tomography scanning (CT-Scan) image reported a lung hydatid cyst. In the pediatrics ward, a broad-spectrum antibiotics regimen with triple-antibiotic therapy (linezolid, vancomycin, and metronidazole) was instituted and continued for a week with no response, but worsening of the condition. In the pediatric surgery ward, our decision for surgical intervention was due to the failure of medical treatment because of a pulmonary lesion. Our team performed right lung upper lobe anterior segment wedge resection due to necrotizing pneumonia and followed the patient 45 days post-operation with a reasonable result. CONCLUSION: Living in remote rural areas with low resources and inaccessibility to proper and specialized diagnostic and treatment centers will all contribute to an improper diagnosis and treatment of lung infection. In total, all of these will increase the morbidity and mortality due to lung necrosis in the pediatric population, regardless of their age. In low-resource facilities, high-risk patients can benefit from surgical intervention to control the ongoing infection process.


Echinococcosis , Leukopenia , Pneumonia, Necrotizing , Pneumonia , Male , Child , Humans , Pneumonia, Necrotizing/diagnosis , Pneumonia, Necrotizing/surgery , Pneumonia, Necrotizing/drug therapy , Lung/diagnostic imaging , Lung/surgery , Lung/pathology , Pneumonia/diagnosis , Pneumonia/etiology , Pneumonia/drug therapy , Anti-Bacterial Agents/therapeutic use , Echinococcosis/drug therapy , Echinococcosis/pathology
...